Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2018

01.10.2018 | Sarcoma

Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis

verfasst von: Falk Roeder, MD, Antonino de Paoli, MD, Ladan Saleh-Ebrahimi, MD, Ingo Alldinger, MD, Giulio Bertola, MD, Giovanni Boz, MD, Federico Navarria, MD, Miguel Cuervo, MD, Matthias Uhl, MD, Ana Alvarez, MD, Markus Buechler, MD, Burkhard Lehner, MD, Juergen Debus, MD, PhD, Felipe A. Calvo, MD, Robert Krempien, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We report a pooled analysis evaluating the combination of gross complete limb-sparing surgery, intraoperative electron radiation therapy (IOERT), and external beam radiation therapy (EBRT) in patients with extremity soft tissue sarcoma (STS).

Methods

Individual data of 259 patients (median follow-up 63 months) with extremity STS from three European expert centers were pooled. Median age was 55 years and median tumor size was 8 cm. Eighty percent of patients presented with primary disease, mainly located in the lower limb (81%). Union for International Cancer Control 7th edition stage at presentation was as follows: stage I: 9%; stage II: 47%; stage III: 39%; stage IV: 5%. Most patients showed high-grade lesions (91%), predominantly liposarcoma (31%). Median IOERT dose was 12 Gy, preceeded (17%) or followed (83%) by EBRT, with a median dose of 45 Gy.

Results

Surgery resulted in R0 resections in 71% of patients and R1 resections in 29% of patients. The 5-year local control (LC) rate was 86%, and significant factors in univariate analysis were disease status and resection margin. Only margin remained significant in multivariate analysis. The 5-year distant control rate was 69%, and significant factors in univariate analysis were histology, grading, resection margin, and metastases prior to/at IOERT. Only grading and metastases remained significant in multivariate analysis. Actuarial 5-year rates of freedom from treatment failure and OS were 61% and 78%, respectively. Significant factors for OS were grading and metastases prior to/at IOERT (univariate, multivariate). Limb preservation and good functional outcome were achieved in 95% and 81% of patients.

Conclusions

Our pooled analysis confirmed prior reports of encouraging LC and survival, with excellent rates of preserved limb function with this treatment approach. Resection margin remained the most important factor for LC, while grading and metastases prior to/at IOERT mainly predicted survival.
Literatur
1.
Zurück zum Zitat Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities. Ann Surg. 1982;196:305–14.CrossRef Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities. Ann Surg. 1982;196:305–14.CrossRef
3.
Zurück zum Zitat Jebsen NL, Trovik CS, Bauer HC, et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian Sarcoma Group study. Int J Radiat Oncol Biol Phys. 2008;71:1196–1203.CrossRef Jebsen NL, Trovik CS, Bauer HC, et al. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian Sarcoma Group study. Int J Radiat Oncol Biol Phys. 2008;71:1196–1203.CrossRef
4.
Zurück zum Zitat Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity. J Clin Oncol. 1998;16:197–203.CrossRef Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity. J Clin Oncol. 1998;16:197–203.CrossRef
5.
Zurück zum Zitat Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2003;56:473–81.CrossRef Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2003;56:473–81.CrossRef
6.
Zurück zum Zitat Davis AM, O´Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.CrossRef Davis AM, O´Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.CrossRef
7.
Zurück zum Zitat Oertel S, Treiber M, Zahlten-Hinguranage A, et al. Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;64:1416–23.CrossRef Oertel S, Treiber M, Zahlten-Hinguranage A, et al. Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;64:1416–23.CrossRef
8.
Zurück zum Zitat Roeder F, Lehner B, Saleh-Ebrahimi L, et al. Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol. 2016;119:22–9.CrossRef Roeder F, Lehner B, Saleh-Ebrahimi L, et al. Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol. 2016;119:22–9.CrossRef
9.
Zurück zum Zitat Edmonson JH, Petersen IA, Shives TC, et al. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft-tissue sarcomas. Cancer 2002;94:786–92.CrossRef Edmonson JH, Petersen IA, Shives TC, et al. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft-tissue sarcomas. Cancer 2002;94:786–92.CrossRef
10.
Zurück zum Zitat Azinovic I, Martinez Monge R, Javier Aristu J et al. Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcomas of the extremities. Radiother Oncol. 2003;67:331–7.CrossRef Azinovic I, Martinez Monge R, Javier Aristu J et al. Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcomas of the extremities. Radiother Oncol. 2003;67:331–7.CrossRef
11.
Zurück zum Zitat Kretzler A, Molls M, Gradinger R, et al. Intraoperative radiotherapy of soft tissue sarcomas of the extremity. Strahlenther Onkol. 2004;180:365–70.CrossRef Kretzler A, Molls M, Gradinger R, et al. Intraoperative radiotherapy of soft tissue sarcomas of the extremity. Strahlenther Onkol. 2004;180:365–70.CrossRef
12.
Zurück zum Zitat Llacer C, Delannes M, Minsat M, et al. Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure. Radiother Oncol. 2006;78:10–6.CrossRef Llacer C, Delannes M, Minsat M, et al. Low-dose intraoperative brachytherapy in soft tissue sarcomas involving neurovascular structure. Radiother Oncol. 2006;78:10–6.CrossRef
13.
Zurück zum Zitat Roeder FF, Schulz-Ertner D, Nikoghosyan AV, et al. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma. BMC Cancer. 2012;12:287.CrossRef Roeder FF, Schulz-Ertner D, Nikoghosyan AV, et al. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma. BMC Cancer. 2012;12:287.CrossRef
14.
Zurück zum Zitat Roeder FF, Timke C, Saleh-Ebrahimi L, et al. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer—NEOPANC. BMC Cancer. 2012;12:112.CrossRef Roeder FF, Timke C, Saleh-Ebrahimi L, et al. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer—NEOPANC. BMC Cancer. 2012;12:112.CrossRef
15.
Zurück zum Zitat Roeder F, Ulrich A, Habl G, et al. Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis. BMC Cancer. 2014;14:617.CrossRef Roeder F, Ulrich A, Habl G, et al. Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis. BMC Cancer. 2014;14:617.CrossRef
16.
Zurück zum Zitat Roeder F, Timke C, Uhl M, et al. Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis. BMC Cancer. 2012;12:295.CrossRef Roeder F, Timke C, Uhl M, et al. Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis. BMC Cancer. 2012;12:295.CrossRef
17.
Zurück zum Zitat Roeder F, Goetz JM, Habl G, et al. Intraoperative electron radiation therapy (IOERT) in the management of locally recurrent rectal cancer. BMC Cancer. 2012;12:592.CrossRef Roeder F, Goetz JM, Habl G, et al. Intraoperative electron radiation therapy (IOERT) in the management of locally recurrent rectal cancer. BMC Cancer. 2012;12:592.CrossRef
18.
Zurück zum Zitat Roeder F, Timke C, Oertel S, et al. Intraoperative electron radiotherapy for the management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 2010;76:1154–60.CrossRef Roeder F, Timke C, Oertel S, et al. Intraoperative electron radiotherapy for the management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys. 2010;76:1154–60.CrossRef
19.
Zurück zum Zitat Roeder F, Krempien R. Intraoperative radiation therapy (IORT) in soft-tissue sarcoma. Radiat Oncol. 2017;12:20.CrossRef Roeder F, Krempien R. Intraoperative radiation therapy (IORT) in soft-tissue sarcoma. Radiat Oncol. 2017;12:20.CrossRef
20.
Zurück zum Zitat Calvo FA, Sole CV, Polo A, et al. Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy for boost for patients with primary soft tissue sarcoma of the extremity: a multicentric pooled analysis of long-term outcomes. Strahlenther Onkol. 2014;190:891–8.CrossRef Calvo FA, Sole CV, Polo A, et al. Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy for boost for patients with primary soft tissue sarcoma of the extremity: a multicentric pooled analysis of long-term outcomes. Strahlenther Onkol. 2014;190:891–8.CrossRef
21.
Zurück zum Zitat de Paoli A, Bertola G, Boz G, et al. Intraoperative radiation therapy for retroperitoneal soft tissue sarcomas. J Exp Clin Cancer Res. 2003;22 Suppl 4:157–61.PubMed de Paoli A, Bertola G, Boz G, et al. Intraoperative radiation therapy for retroperitoneal soft tissue sarcomas. J Exp Clin Cancer Res. 2003;22 Suppl 4:157–61.PubMed
22.
Zurück zum Zitat De Paoli A, Bertola G, Boz G, et al. Radiation therapy and conservative surgery for soft tissue sarcomas of the extremities, torso and head and neck. Ann Oncol. 1992;3 Suppl 2:97–101.CrossRef De Paoli A, Bertola G, Boz G, et al. Radiation therapy and conservative surgery for soft tissue sarcomas of the extremities, torso and head and neck. Ann Oncol. 1992;3 Suppl 2:97–101.CrossRef
23.
Zurück zum Zitat Roeder F, Lehner B, Schmitt T, et al. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer. 2014;14:350.CrossRef Roeder F, Lehner B, Schmitt T, et al. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer. 2014;14:350.CrossRef
24.
Zurück zum Zitat Alvarez A, Calvo FA, Gonzales C, et al. IORT in soft tissue sarcomas involving extremities: toxicities and long-term functional results [abstract]. Revisiones en cancer. 2008;22:s55. Alvarez A, Calvo FA, Gonzales C, et al. IORT in soft tissue sarcomas involving extremities: toxicities and long-term functional results [abstract]. Revisiones en cancer. 2008;22:s55.
25.
Zurück zum Zitat Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcomas treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.CrossRef Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcomas treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.CrossRef
26.
Zurück zum Zitat Hui AC, Ngan SY, Wong K, Powell G, Choong PF. Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre Experience. Eur J Surg Oncol. 2006;32:1159–64.CrossRef Hui AC, Ngan SY, Wong K, Powell G, Choong PF. Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre Experience. Eur J Surg Oncol. 2006;32:1159–64.CrossRef
27.
Zurück zum Zitat Dagan R, Indelicato DJ, McGee L, et al. The significance of a marginal excision after preoperative radiation therapy of soft tissue sarcoma of the extremity. Cancer. 2012;118:3199–207.CrossRef Dagan R, Indelicato DJ, McGee L, et al. The significance of a marginal excision after preoperative radiation therapy of soft tissue sarcoma of the extremity. Cancer. 2012;118:3199–207.CrossRef
28.
Zurück zum Zitat Kraybill WG, Harris J, Spiro IJ, et al. Phase II Study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation therapy oncology group trial 9514. J Clin Oncol. 2006;24:619–25.CrossRef Kraybill WG, Harris J, Spiro IJ, et al. Phase II Study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: radiation therapy oncology group trial 9514. J Clin Oncol. 2006;24:619–25.CrossRef
29.
Zurück zum Zitat Felderhof JM, Creutzberg CL, Putter H, et al. Long term clinical outcome of patients with soft-tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy. Acta Oncologica. 2012;52:745–52.CrossRef Felderhof JM, Creutzberg CL, Putter H, et al. Long term clinical outcome of patients with soft-tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy. Acta Oncologica. 2012;52:745–52.CrossRef
30.
Zurück zum Zitat Alektiar KM, Brennan MF, Singer S. Local Control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity. Cancer. 2011;117:3229–34.CrossRef Alektiar KM, Brennan MF, Singer S. Local Control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity. Cancer. 2011;117:3229–34.CrossRef
31.
Zurück zum Zitat Lee J, Park YJ, Yang DS, et al. Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma. Radiat Oncol J. 2012;30:62–9.CrossRef Lee J, Park YJ, Yang DS, et al. Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma. Radiat Oncol J. 2012;30:62–9.CrossRef
32.
Zurück zum Zitat Folkert M, Singer S, Brennan MF, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014:32:3236–41.CrossRef Folkert M, Singer S, Brennan MF, et al. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014:32:3236–41.CrossRef
33.
Zurück zum Zitat Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21:2719–25.CrossRef Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21:2719–25.CrossRef
34.
Zurück zum Zitat Alamanda VK, Crosby SN, Archer KR, et al. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol. 2013;52:793–802.CrossRef Alamanda VK, Crosby SN, Archer KR, et al. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol. 2013;52:793–802.CrossRef
35.
Zurück zum Zitat Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.CrossRef Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.CrossRef
36.
Zurück zum Zitat Biau DJ, Ferguson PC, Chung P, et al. Local recurrence of localized soft tissue sarcoma. Cancer. 2012;118:5867–77.CrossRef Biau DJ, Ferguson PC, Chung P, et al. Local recurrence of localized soft tissue sarcoma. Cancer. 2012;118:5867–77.CrossRef
37.
Zurück zum Zitat Gronchi A, Miceli R, Colombo C, et al. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol. 2011;22:1675–81.CrossRef Gronchi A, Miceli R, Colombo C, et al. Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol. 2011;22:1675–81.CrossRef
38.
Zurück zum Zitat Müller DA, Beltrami G, Scoccianti G, et al. Combining limb sparing surgery with radiation therapy in high-grade soft tissue sarcoma of extremities—is it effective? Eur J Surg Oncol. 2016;42:1057–1063.CrossRef Müller DA, Beltrami G, Scoccianti G, et al. Combining limb sparing surgery with radiation therapy in high-grade soft tissue sarcoma of extremities—is it effective? Eur J Surg Oncol. 2016;42:1057–1063.CrossRef
39.
Zurück zum Zitat Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas—factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218–26.PubMedPubMedCentral Eilber FC, Rosen G, Nelson SD, et al. High-grade extremity soft tissue sarcomas—factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218–26.PubMedPubMedCentral
40.
Zurück zum Zitat Delaney TF, Kepka L, Goldberg SI, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007;67:1460–69.CrossRef Delaney TF, Kepka L, Goldberg SI, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007;67:1460–69.CrossRef
41.
Zurück zum Zitat O’Sullivan B, Griffin AM, Dickie CL, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft-tissue sarcoma. Cancer. 2013;119:1878–94.CrossRef O’Sullivan B, Griffin AM, Dickie CL, et al. Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft-tissue sarcoma. Cancer. 2013;119:1878–94.CrossRef
42.
Zurück zum Zitat Al Yami A, Griffin AM, Ferguson PC, et al. Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys. 2010;4:1191–97.CrossRef Al Yami A, Griffin AM, Ferguson PC, et al. Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys. 2010;4:1191–97.CrossRef
43.
Zurück zum Zitat Stinson SF, DeLaney TF, Greenberg J, et al. Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1991;21:1493–99.CrossRef Stinson SF, DeLaney TF, Greenberg J, et al. Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1991;21:1493–99.CrossRef
44.
Zurück zum Zitat Alektiar KM, Hong L, Brennan MF, Della-Biancia C, Singer S. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. Int J Radiat Oncol Biol Phys. 2007;68:458–64.CrossRef Alektiar KM, Hong L, Brennan MF, Della-Biancia C, Singer S. Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results. Int J Radiat Oncol Biol Phys. 2007;68:458–64.CrossRef
45.
Zurück zum Zitat Dickie CI, Parent AL, Chung PW, et al. Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization sytem for lower extremity soft tissue sarcoma patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2010;78:1437–44.CrossRef Dickie CI, Parent AL, Chung PW, et al. Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization sytem for lower extremity soft tissue sarcoma patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2010;78:1437–44.CrossRef
46.
Zurück zum Zitat Wang D, Zhang Q, Eisenberg BL, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of a radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33:2231–38.CrossRef Wang D, Zhang Q, Eisenberg BL, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of a radiation therapy oncology group RTOG-0630 trial. J Clin Oncol. 2015;33:2231–38.CrossRef
47.
Zurück zum Zitat Alamanda VK, Song Y, Shinohara E, et al. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. J Med Imag Radiat Oncol. 2014;58:633–40.CrossRef Alamanda VK, Song Y, Shinohara E, et al. Postoperative radiation boost does not improve local recurrence rates in extremity soft tissue sarcomas. J Med Imag Radiat Oncol. 2014;58:633–40.CrossRef
48.
Zurück zum Zitat Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Sem Radiat Oncol. 2008;18:234–39.CrossRef Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Sem Radiat Oncol. 2008;18:234–39.CrossRef
49.
Zurück zum Zitat Mallick S, Benson R, Julka PK, Rath GK. Shifting paradigm in the management of anal canal carcinomas. J Gastrointest Cancer. 2015;46:1–4.CrossRef Mallick S, Benson R, Julka PK, Rath GK. Shifting paradigm in the management of anal canal carcinomas. J Gastrointest Cancer. 2015;46:1–4.CrossRef
50.
Zurück zum Zitat Callister MD, Beauchamp CP, Fitch TR, Gunderson LL. Preoperative radiation and IOERT for soft-tissue sarcomas of the extremities and trunk [abstract]. Revisiones en Cancer. 2008;22:54. Callister MD, Beauchamp CP, Fitch TR, Gunderson LL. Preoperative radiation and IOERT for soft-tissue sarcomas of the extremities and trunk [abstract]. Revisiones en Cancer. 2008;22:54.
Metadaten
Titel
Intraoperative Electron Radiation Therapy Combined with External Beam Radiation Therapy after Gross Total Resection in Extremity Soft Tissue Sarcoma: A European Pooled Analysis
verfasst von
Falk Roeder, MD
Antonino de Paoli, MD
Ladan Saleh-Ebrahimi, MD
Ingo Alldinger, MD
Giulio Bertola, MD
Giovanni Boz, MD
Federico Navarria, MD
Miguel Cuervo, MD
Matthias Uhl, MD
Ana Alvarez, MD
Markus Buechler, MD
Burkhard Lehner, MD
Juergen Debus, MD, PhD
Felipe A. Calvo, MD
Robert Krempien, MD
Publikationsdatum
01.10.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6787-9

Weitere Artikel der Ausgabe 13/2018

Annals of Surgical Oncology 13/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.